ScanSource (SCSC) Financials

$45.90 +2.61 (+6.03%)

Closing price 05/8/2026 04:00 PM Eastern

Extended Trading

$45.90 0.00 (0.00%)

As of 05/8/2026 07:59 PM Eastern

Annual Income Statements for ScanSource

This table shows ScanSource's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Net Income / (Loss) Attributable to Common Shareholders	65	64	69	33	58	-193	11	89	90	77	72
Consolidated Net Income / (Loss)	65	64	69	33	58	-193	11	89	90	77	72
Net Income / (Loss) Continuing Operations	65	64	69	35	65	-79	45	89	88	77	72
Total Pre-Tax Income	100	96	101	63	84	-72	58	119	122	100	94
Total Operating Income	101	97	88	69	95	-65	61	122	136	90	85
Total Gross Profit	327	355	384	369	393	356	351	427	449	399	409
Total Revenue	3,219	3,540	3,568	3,165	3,250	3,048	3,151	3,530	3,788	3,260	3,041
Operating Revenue	3,219	3,540	3,568	3,165	3,250	3,048	3,151	3,530	3,788	3,260	3,041
Total Cost of Revenue	2,892	3,185	3,185	2,795	2,857	2,692	2,800	3,103	3,338	2,861	2,632
Operating Cost of Revenue	2,892	3,185	3,185	2,795	2,857	2,692	2,800	3,103	3,338	2,861	2,632
Total Operating Expenses	226	259	295	300	298	421	289	304	313	309	323
Selling, General & Admin Expense	211	240	265	232	244	260	247	275	286	277	287
Depreciation Expense	5.36	7.33	9.40	12	12	13	13	11	11	11	10
Amortization Expense	6.60	9.80	16	19	18	20	19	18	17	16	19
Restructuring Charge	-	-	-	-	8.65	0.60	9.26	0.00	0.00	4.36	5.38
Other Special Charges / (Income)	2.67	1.29	5.21	37	15	6.94	0.52	-	0.00	0.00	1.90
Total Other Income / (Expense), net	-1.54	-0.87	13	-5.96	-11	-6.81	-3.95	-3.54	-14	9.52	9.20
Interest Expense	1.80	2.12	3.22	9.12	13	12	6.93	6.52	20	13	8.01
Interest & Investment Income	2.64	3.45	5.33	3.71	1.82	5.83	3.10	4.33	7.41	9.38	11
Other Income / (Expense), net	-2.38	-2.19	11	-0.55	0.25	-0.41	-0.12	-1.35	-1.66	13	5.96
Income Tax Expense	34	32	32	28	19	7.45	12	30	34	23	23
Net Income / (Loss) Discontinued Operations	-	-	-	-2.30	-7.26	-113	-35	0.10	1.72	0.00	0.00
Basic Earnings per Share	$2.29	$2.40	$2.74	$1.30	$2.25	($7.59)	$0.42	$3.48	$3.57	$3.10	$3.05
Weighted Average Basic Shares Outstanding	28.56M	26.47M	25.32M	25.52M	25.64M	25.38M	25.42M	25.50M	25.14M	24.87M	23.44M
Diluted Earnings per Share	$2.27	$2.38	$2.71	$1.29	$2.24	($7.59)	$0.42	$3.45	$3.54	$3.06	$3.00
Weighted Average Diluted Shares Outstanding	28.80M	26.69M	25.52M	25.62M	25.73M	25.38M	25.52M	25.76M	25.36M	25.22M	23.84M
Weighted Average Basic & Diluted Shares Outstanding	28.60M	26.50M	25.30M	25.50M	25.24M	25.36M	25.50M	25.19M	24.84M	24.03M	21.88M

This table shows ScanSource's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	19	15	33	13	16	17	17	17	20	20	16
Consolidated Net Income / (Loss)	19	15	33	13	16	17	17	17	20	20	16
Net Income / (Loss) Continuing Operations	17	15	33	13	16	17	17	17	20	20	16
Total Pre-Tax Income	23	19	40	18	23	23	20	24	27	27	19
Total Operating Income	27	24	27	18	22	18	18	22	27	26	18
Total Gross Profit	109	107	101	94	97	102	102	100	105	107	103
Total Revenue	947	876	885	753	746	776	747	705	813	740	767
Operating Revenue	947	876	885	753	746	776	747	705	813	740	767
Total Cost of Revenue	838	770	784	658	649	674	646	605	708	632	664
Operating Cost of Revenue	838	770	784	658	649	674	646	605	708	632	664
Total Operating Expenses	81	82	74	77	75	84	83	78	78	82	85
Selling, General & Admin Expense	74	75	67	67	68	72	74	70	72	75	78
Depreciation Expense	2.83	2.80	2.96	2.69	2.77	2.86	2.90	2.32	1.93	1.58	1.43
Amortization Expense	4.19	4.19	4.04	3.75	3.74	4.36	5.00	4.94	4.93	4.40	4.29
Restructuring Charge	-	0.00	0.00	3.92	-	5.07	0.31	0.00	-	0.00	0.00
Other Special Charges / (Income)	-	-	0.00	0.00	-	0.00	1.14	0.90	-	0.31	1.21
Total Other Income / (Expense), net	-3.83	-4.94	13	0.41	0.82	5.33	1.27	1.89	0.71	1.09	1.55
Interest Expense	5.56	5.59	3.36	2.00	2.09	2.11	1.97	1.84	2.10	1.91	1.95
Interest & Investment Income	2.09	1.33	2.12	2.65	3.29	2.66	2.69	2.84	3.05	3.18	3.36
Other Income / (Expense), net	-0.35	-0.68	14	-0.24	-0.38	4.78	0.54	0.88	-0.25	-0.17	0.14
Income Tax Expense	6.37	3.72	7.32	5.15	6.60	5.99	2.66	6.80	7.41	7.12	2.93
Basic Earnings per Share	$0.76	$0.62	$1.31	$0.51	$0.66	$0.70	$0.72	$0.75	$0.88	$0.90	$0.75
Weighted Average Basic Shares Outstanding	25.14M	24.89M	25.04M	25.03M	24.87M	24.15M	23.81M	23.28M	23.44M	22.02M	21.87M
Diluted Earnings per Share	$0.76	$0.61	$1.29	$0.50	$0.66	$0.69	$0.70	$0.74	$0.87	$0.89	$0.75
Weighted Average Diluted Shares Outstanding	25.36M	25.18M	25.33M	25.44M	25.22M	24.65M	24.22M	23.60M	23.84M	22.41M	22.11M
Weighted Average Basic & Diluted Shares Outstanding	24.84M	24.97M	25.17M	24.71M	24.03M	0.00	23.46M	22.60M	21.88M	21.94M	21.48M

This table details how cash moves in and out of ScanSource's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Net Change in Cash & Equivalents	-73	-60	-4.87	-35	-1.71	11	28	-25	-1.81	149	-59
Net Cash From Operating Activities	76	52	95	25	16	182	117	-124	-36	372	112
Net Cash From Continuing Operating Activities	76	52	95	31	16	182	117	-124	-36	372	112
Net Income / (Loss) Continuing Operations	65	64	69	35	65	-79	45	89	88	77	72
Consolidated Net Income / (Loss)	65	64	69	33	58	-193	11	89	90	77	72
Net Income / (Loss) Discontinued Operations	-	-	-	-2.30	-7.26	-113	-35	0.10	1.72	0.00	0.00
Depreciation Expense	12	17	25	34	34	35	34	30	29	28	30
Amortization Expense	0.30	0.30	0.29	0.33	0.35	0.42	0.42	0.42	0.58	0.39	0.39
Non-Cash Adjustments To Reconcile Net Income	7.26	15	15	9.44	-2.43	125	5.96	13	14	3.80	19
Changes in Operating Assets and Liabilities, net	-9.45	-43	-15	-48	-80	101	31	-257	-167	262	-9.28
Net Cash From Discontinued Operating Activities	-	-	-	-6.64	-	-	-	0.00	0.00	0.00	0.00
Net Cash From Investing Activities	-81	-74	-96	-152	-38	-55	32	-3.72	-8.26	9.05	-62
Net Cash From Continuing Investing Activities	-81	-74	-96	-151	-38	-55	32	-3.72	-8.26	9.05	-62
Purchase of Property, Plant & Equipment	-21	-12	-8.85	-7.00	-5.80	-6.39	-2.36	-6.85	-9.98	-8.56	-8.29
Acquisitions	-60	-61	-87	-144	-32	-49	-	-	0.00	0.00	-57
Divestitures	-	-	-	-	0.00	0.00	34	3.13	1.72	18	2.57
Net Cash From Discontinued Investing Activities	-	-	-	-1.16	-	-	-	0.00	0.00	0.00	0.00
Net Cash From Financing Activities	-57	-36	-3.51	101	31	-153	-119	108	40	-228	-111
Net Cash From Continuing Financing Activities	-57	-36	-3.51	101	31	-153	-119	108	40	-228	-111
Repayment of Debt	-133	-1,308	-1,794	-2,150	-2,134	-2,196	-1,957	-2,040	-2,442	-1,447	-61
Repurchase of Common Equity	-19	-100	-21	0.00	-9.48	-6.08	0.00	-18	-16	-43	-107
Issuance of Debt	94	1,377	1,813	2,301	2,211	2,086	1,882	2,166	2,499	1,260	52
Other Financing Activities, net	1.02	-4.51	-1.94	-50	-36	-36	-43	-0.45	-1.55	1.94	4.62
Net Cash From Discontinued Financing Activities	-	-	-	-0.35	-	-	-	0.00	0.00	0.00	0.00
Effect of Exchange Rate Changes	-11	-2.60	-	-	0.56	-3.64	3.71	-4.76	2.69	-3.64	1.64
Cash Interest Paid	1.08	1.71	2.83	8.61	13	12	6.41	6.07	19	13	7.57
Cash Income Taxes Paid	36	34	31	36	31	17	12	29	29	27	28

This table details how cash moves in and out of ScanSource's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Net Change in Cash & Equivalents	-1.20	6.47	2.34	114	26	-40	-35	36	-20	-1.23	-41
Net Cash From Operating Activities	-15	94	63	160	55	45	-6.19	66	7.65	23	31
Net Cash From Continuing Operating Activities	-15	94	63	160	55	45	-6.19	66	7.65	23	31
Net Income / (Loss) Continuing Operations	17	15	33	13	16	17	17	17	20	20	16
Consolidated Net Income / (Loss)	19	15	33	13	16	17	17	17	20	20	16
Depreciation Expense	7.26	7.22	7.26	6.74	6.79	7.47	8.13	7.49	7.10	6.20	5.94
Amortization Expense	0.10	0.10	0.10	0.10	0.10	0.10	0.10	0.10	0.10	0.10	0.34
Non-Cash Adjustments To Reconcile Net Income	3.53	6.94	-12	3.80	4.67	4.17	7.29	4.69	3.34	4.82	7.33
Changes in Operating Assets and Liabilities, net	-43	64	35	137	27	16	-39	36	-23	-7.78	0.75
Net Cash From Investing Activities	-1.71	-2.32	15	-2.42	-1.65	-59	0.77	-1.42	-2.52	-2.40	-20
Net Cash From Continuing Investing Activities	-1.71	-2.32	15	-2.42	-1.65	-59	0.77	-1.42	-2.52	-2.40	-20
Purchase of Property, Plant & Equipment	-3.43	-2.32	-2.55	-2.42	-1.27	-2.38	-1.97	-1.42	-2.52	-2.40	-1.98
Acquisitions	-	0.00	-	-	-	-57	0.18	-	-	0.00	-18
Net Cash From Financing Activities	14	-83	-78	-43	-24	-27	-26	-31	-27	-23	-50
Net Cash From Continuing Financing Activities	14	-83	-78	-43	-24	-27	-26	-31	-27	-23	-50
Repayment of Debt	-608	-671	-626	-131	-19	-9.06	-22	-14	-16	-52	-225
Repurchase of Common Equity	-4.93	0.00	-1.25	-20	-22	-28	-24	-29	-25	-21	-17
Issuance of Debt	627	589	546	108	17	8.38	18	12	14	49	193
Other Financing Activities, net	0.03	-1.51	3.16	0.18	0.11	2.18	2.51	0.00	-0.07	0.84	0.00
Effect of Exchange Rate Changes	1.81	-1.26	1.50	-1.03	-2.86	0.61	-3.38	2.19	2.22	0.90	-1.65

This table presents ScanSource's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Total Assets	1,477	1,491	1,718	1,945	2,067	1,692	1,672	1,937	2,068	1,779	1,786
Total Current Assets	1,244	1,229	1,281	1,362	1,477	1,203	1,220	1,524	1,657	1,405	1,370
Cash & Equivalents	122	61	56	26	19	29	63	38	36	185	126
Accounts Receivable	523	560	637	646	523	443	569	729	753	582	636
Inventories, net	553	559	531	596	554	455	470	615	758	513	484
Prepaid Expenses	47	49	56	95	84	95	118	142	110	125	122
Current Deferred & Refundable Income Taxes	-	-	-	-	-	-	-	-	-	-	2.82
Plant, Property, & Equipment, net	47	52	57	73	0.00	0.00	0.00	0.00	0.00	34	31
Total Noncurrent Assets	186	210	381	510	590	489	452	414	411	341	384
Goodwill	67	93	201	298	311	214	219	214	217	206	231
Intangible Assets	46	51	102	137	121	122	105	84	68	38	63
Noncurrent Deferred & Refundable Income Taxes	39	29	29	22	15	25	22	16	18	20	19
Other Noncurrent Operating Assets	34	37	49	53	113	128	106	99	108	77	71
Total Liabilities & Shareholders' Equity	1,477	1,491	1,718	1,945	2,067	1,692	1,672	1,937	2,068	1,779	1,786
Total Liabilities	668	717	881	1,079	1,153	1,014	940	1,131	1,163	855	879
Total Current Liabilities	599	585	656	710	701	719	733	814	787	669	683
Short-Term Debt	12	12	31	44	42	54	7.84	12	6.92	7.86	9.18
Accounts Payable	501	471	513	563	488	454	635	714	691	588	599
Current Deferred & Payable Income Tax Liabilities	4.18	3.06	7.73	13	3.96	5.89	2.50	0.03	9.88	7.90	3.93
Other Current Liabilities	81	99	105	91	65	77	88	88	79	66	71
Total Noncurrent Liabilities	69	132	225	369	452	295	208	317	376	185	196
Long-Term Debt	5.97	77	97	249	323	211	135	260	323	136	128
Other Noncurrent Operating Liabilities	59	52	126	118	97	80	68	54	49	49	68
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	809	774	837	866	914	678	731	807	905	924	906
Total Preferred & Common Equity	809	774	837	866	914	678	731	807	905	924	906
Preferred Stock	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	809	774	837	866	914	678	731	807	905	924	906
Common Stock	157	67	61	68	64	64	71	64	58	26	0.00
Retained Earnings	716	780	849	882	940	747	758	847	937	1,014	1,021
Accumulated Other Comprehensive Income / (Loss)	-65	-73	-73	-84	-90	-133	-98	-105	-90	-116	-114

This table presents ScanSource's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026
Period end date	9/30/2022	12/31/2022	3/31/2023	9/30/2023	12/31/2023	3/31/2024	9/30/2024	12/31/2024	3/31/2025	9/30/2025	12/31/2025
Total Assets	2,000	2,131	1,980	1,899	1,781	1,783	1,787	1,703	1,725	1,717	1,742
Total Current Assets	1,588	1,719	1,578	1,507	1,405	1,416	1,352	1,284	1,310	1,307	1,303
Cash & Equivalents	40	66	37	43	45	159	145	111	146	125	83
Accounts Receivable	745	780	684	692	663	590	567	549	563	557	605
Inventories, net	676	762	753	656	575	529	504	492	476	505	490
Prepaid Expenses	126	111	103	117	122	138	136	132	125	120	113
Current Deferred & Refundable Income Taxes	-	-	-	-	-	-	-	-	-	-	11
Plant, Property, & Equipment, net	0.00	0.00	36	0.00	0.00	36	33	30	30	32	32
Total Noncurrent Assets	413	411	366	391	376	331	401	389	385	377	406
Goodwill	212	214	215	215	208	208	233	228	229	231	244
Intangible Assets	79	76	72	64	45	42	78	73	68	59	72
Noncurrent Deferred & Refundable Income Taxes	13	15	14	16	19	19	17	18	18	17	14
Other Noncurrent Operating Assets	109	106	65	96	103	63	73	70	70	71	76
Total Liabilities & Shareholders' Equity	2,000	2,131	1,980	1,899	1,781	1,783	1,787	1,703	1,725	1,717	1,742
Total Liabilities	1,173	1,268	1,101	983	827	839	866	802	823	803	831
Total Current Liabilities	794	837	744	701	611	643	666	610	632	606	664
Short-Term Debt	4.10	5.04	5.98	8.21	7.86	7.86	12	9.90	9.60	9.65	19
Accounts Payable	711	749	657	618	541	556	579	520	541	530	577
Current Deferred & Payable Income Tax Liabilities	5.27	6.05	4.44	8.11	3.65	4.79	6.38	8.33	13	3.56	0.27
Other Current Liabilities	74	77	77	67	58	75	69	71	68	63	68
Total Noncurrent Liabilities	379	431	357	282	217	196	200	192	192	197	167
Long-Term Debt	322	378	305	240	161	138	134	132	130	126	100
Other Noncurrent Operating Liabilities	54	51	49	39	56	58	66	60	61	71	67
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	827	862	879	915	954	944	921	901	902	914	911
Total Preferred & Common Equity	827	862	879	915	954	944	921	901	902	914	911
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	827	862	879	915	954	944	921	901	902	914	911
Common Stock	66	68	60	60	64	46	2.98	0.00	0.00	0.00	0.00
Retained Earnings	871	897	918	952	985	998	1,031	1,032	1,023	1,025	1,027
Accumulated Other Comprehensive Income / (Loss)	-110	-103	-99	-96	-95	-100	-113	-131	-122	-111	-116

This table displays calculated financial ratios and metrics derived from ScanSource's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	10.47%	9.99%	0.79%	-11.31%	2.69%	-6.22%	3.38%	12.03%	7.30%	-13.94%	-6.72%
EBITDA Growth	-13.78%	0.70%	11.15%	-17.14%	24.89%	-122.97%	421.57%	58.58%	8.14%	-19.29%	-7.69%
EBIT Growth	-18.45%	-4.42%	4.96%	-31.11%	38.74%	-168.83%	193.86%	96.87%	11.10%	-22.90%	-11.91%
NOPAT Growth	-17.91%	-3.36%	-6.22%	-35.54%	89.31%	-161.90%	206.66%	88.33%	7.54%	-29.04%	-7.37%
Net Income Growth	-20.01%	-2.75%	8.84%	-52.12%	73.73%	-434.49%	105.60%	722.58%	1.14%	-14.20%	-7.15%
EPS Growth	-20.63%	4.85%	13.87%	-52.40%	73.64%	-438.84%	105.53%	721.43%	2.61%	-13.56%	-1.96%
Operating Cash Flow Growth	58.25%	-30.87%	81.72%	-73.85%	-35.37%	1,035.44%	-35.85%	-206.50%	71.24%	1,139.02%	-69.77%
Free Cash Flow Firm Growth	-206.74%	-58.51%	-48.69%	-292.19%	174.51%	17.60%	-40.01%	-240.26%	55.33%	731.87%	-92.30%
Invested Capital Growth	13.97%	13.60%	13.41%	24.67%	-5.71%	-19.46%	-5.69%	28.10%	15.32%	-26.37%	3.95%
Revenue Q/Q Growth	3.16%	0.59%	1.13%	-16.05%	0.78%	10.87%	7.37%	3.20%	-0.40%	-5.81%	2.25%
EBITDA Q/Q Growth	-10.73%	-5.16%	4.66%	-0.64%	3.06%	-127.79%	332.09%	2.03%	-0.16%	-4.28%	4.60%
EBIT Q/Q Growth	-13.42%	-6.64%	4.05%	-1.01%	4.42%	-188.87%	181.14%	2.89%	0.15%	-4.99%	5.86%
NOPAT Q/Q Growth	-13.46%	-4.95%	8.26%	-11.92%	12.45%	-180.86%	192.09%	-0.06%	-1.05%	-6.15%	6.68%
Net Income Q/Q Growth	-14.01%	-5.25%	9.56%	-20.56%	2.11%	-632.38%	104.69%	-4.07%	-1.25%	-3.40%	5.91%
EPS Q/Q Growth	-14.02%	-2.86%	9.27%	-20.37%	2.28%	-634.51%	104.63%	-4.43%	-0.56%	-3.16%	7.53%
Operating Cash Flow Q/Q Growth	79.01%	-28.18%	-15.31%	448.56%	147.06%	22.45%	-9.74%	-893.38%	63.94%	23.21%	-29.54%
Free Cash Flow Firm Q/Q Growth	64.11%	-119.98%	-76.21%	19.25%	393.62%	55.20%	-71.04%	-942.69%	43.81%	30.38%	-69.12%
Invested Capital Q/Q Growth	-2.99%	-0.96%	1.94%	-2.76%	-16.37%	-29.99%	-3.39%	10.07%	4.03%	-5.16%	2.51%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	10.16%	10.04%	10.75%	11.67%	12.09%	11.67%	11.13%	12.08%	11.86%	12.24%	13.44%
EBITDA Margin	3.46%	3.17%	3.49%	3.26%	3.97%	-0.97%	3.02%	4.28%	4.31%	4.05%	4.00%
Operating Margin	3.15%	2.74%	2.47%	2.18%	2.92%	-2.13%	1.95%	3.46%	3.59%	2.77%	2.80%
EBIT Margin	3.08%	2.67%	2.79%	2.16%	2.92%	-2.15%	1.95%	3.42%	3.54%	3.17%	3.00%
Profit (Net Income) Margin	2.03%	1.80%	1.94%	1.05%	1.77%	-6.32%	0.34%	2.52%	2.37%	2.36%	2.35%
Tax Burden Percent	65.48%	66.26%	68.23%	52.58%	68.87%	268.41%	18.76%	74.86%	73.70%	77.18%	75.80%
Interest Burden Percent	100.85%	101.40%	102.13%	92.10%	88.06%	109.79%	93.76%	98.19%	90.78%	96.47%	103.55%
Effective Tax Rate	34.52%	33.74%	31.77%	43.76%	22.45%	0.00%	21.11%	25.23%	27.70%	22.82%	24.20%
Return on Invested Capital (ROIC)	10.03%	8.52%	7.04%	3.80%	6.67%	-4.71%	5.80%	9.87%	8.78%	6.70%	7.17%
ROIC Less NNEP Spread (ROIC-NNEP)	10.73%	10.02%	25.32%	0.46%	-0.86%	-92.11%	-22.89%	8.24%	5.58%	12.52%	-39.15%
Return on Net Nonoperating Assets (RNNOA)	-1.91%	-0.48%	1.55%	0.09%	-0.20%	-19.48%	-4.27%	1.68%	1.72%	1.73%	0.64%
Return on Equity (ROE)	8.12%	8.04%	8.59%	3.89%	6.47%	-24.20%	1.53%	11.55%	10.49%	8.42%	7.82%
Cash Return on Invested Capital (CROIC)	-3.03%	-4.22%	-5.53%	-18.16%	12.55%	16.84%	11.66%	-14.77%	-5.46%	37.07%	3.30%
Operating Return on Assets (OROA)	7.05%	6.38%	6.19%	3.74%	4.73%	-3.48%	3.65%	6.69%	6.70%	5.38%	5.11%
Return on Assets (ROA)	4.65%	4.29%	4.32%	1.81%	2.87%	-10.25%	0.64%	4.92%	4.48%	4.01%	4.01%
Return on Common Equity (ROCE)	8.12%	8.04%	8.59%	3.89%	6.47%	-24.20%	1.53%	11.55%	10.49%	8.42%	7.82%
Return on Equity Simple (ROE_SIMPLE)	8.09%	8.21%	8.27%	3.83%	6.30%	-28.40%	1.48%	11.01%	9.92%	8.34%	0.00%
Net Operating Profit after Tax (NOPAT)	66	64	60	39	73	-45	49	91	98	70	65
NOPAT Margin	2.06%	1.81%	1.69%	1.23%	2.26%	-1.49%	1.54%	2.59%	2.59%	2.14%	2.12%
Net Nonoperating Expense Percent (NNEP)	-0.70%	-1.50%	-18.28%	3.34%	7.53%	87.40%	28.69%	1.63%	3.20%	-5.82%	46.32%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	-	6.19%
Cost of Revenue to Revenue	89.84%	89.96%	89.25%	88.33%	87.91%	88.33%	88.87%	87.92%	88.14%	87.76%	86.56%
SG&A Expenses to Revenue	6.56%	6.78%	7.43%	7.34%	7.52%	8.52%	7.85%	7.80%	7.54%	8.51%	9.44%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	7.01%	7.30%	8.28%	9.49%	9.17%	13.80%	9.18%	8.62%	8.27%	9.47%	10.64%
Earnings before Interest and Taxes (EBIT)	99	95	99	68	95	-65	61	121	134	103	91
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	111	112	125	103	129	-30	95	151	163	132	122
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.35	1.23	1.22	1.19	0.92	0.90	0.98	0.97	0.81	1.18	1.04
Price to Tangible Book Value (P/TBV)	1.56	1.51	1.91	2.39	1.74	1.78	1.76	1.55	1.19	1.61	1.54
Price to Revenue (P/Rev)	0.34	0.27	0.29	0.33	0.26	0.20	0.23	0.22	0.19	0.34	0.31
Price to Earnings (P/E)	16.65	14.97	14.73	31.08	14.53	0.00	66.36	8.85	8.20	14.21	13.20
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	6.01%	6.68%	6.79%	3.22%	6.88%	0.00%	1.51%	11.30%	12.20%	7.04%	7.57%
Enterprise Value to Invested Capital (EV/IC)	1.40	1.22	1.20	1.14	1.11	0.98	0.98	0.98	0.86	1.19	1.04
Enterprise Value to Revenue (EV/Rev)	0.31	0.28	0.31	0.41	0.36	0.28	0.25	0.29	0.27	0.32	0.31
Enterprise Value to EBITDA (EV/EBITDA)	8.85	8.73	8.76	12.56	9.18	0.00	8.36	6.74	6.30	7.99	7.85
Enterprise Value to EBIT (EV/EBIT)	9.95	10.34	10.99	18.95	12.46	0.00	12.98	8.43	7.67	10.18	10.49
Enterprise Value to NOPAT (EV/NOPAT)	14.84	15.26	18.14	33.43	16.11	0.00	16.43	11.15	10.48	15.11	14.80
Enterprise Value to Operating Cash Flow (EV/OCF)	13.05	18.76	11.51	52.30	73.82	4.65	6.82	0.00	0.00	2.83	8.51
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	8.57	5.21	8.18	0.00	0.00	2.73	32.18
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.02	0.11	0.15	0.34	0.40	0.39	0.20	0.34	0.36	0.16	0.15
Long-Term Debt to Equity	0.01	0.10	0.12	0.29	0.35	0.31	0.19	0.32	0.36	0.15	0.14
Financial Leverage	-0.18	-0.05	0.06	0.20	0.24	0.21	0.19	0.20	0.31	0.14	-0.02
Leverage Ratio	1.74	1.87	1.99	2.15	2.25	2.36	2.39	2.35	2.34	2.10	1.95
Compound Leverage Factor	1.76	1.90	2.03	1.98	1.98	2.59	2.24	2.30	2.12	2.03	2.02
Debt to Total Capital	2.20%	10.25%	13.26%	25.23%	28.58%	28.10%	16.37%	25.16%	26.71%	13.48%	13.17%
Short-Term Debt to Total Capital	1.48%	1.34%	3.18%	3.76%	3.32%	5.74%	0.90%	1.08%	0.56%	0.74%	0.88%
Long-Term Debt to Total Capital	0.72%	8.91%	10.08%	21.48%	25.27%	22.36%	15.48%	24.09%	26.15%	12.74%	12.29%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	97.80%	89.75%	86.74%	74.77%	71.42%	71.90%	83.63%	74.84%	73.29%	86.52%	86.83%
Debt to EBITDA	0.16	0.79	1.03	2.83	2.84	-8.94	1.50	1.79	2.02	1.09	1.13
Net Debt to EBITDA	-0.93	0.24	0.58	2.58	2.69	-7.95	0.84	1.54	1.80	-0.31	0.09
Long-Term Debt to EBITDA	0.05	0.69	0.78	2.41	2.51	-7.12	1.42	1.72	1.98	1.03	1.05
Debt to NOPAT	0.27	1.38	2.13	7.54	4.98	-5.83	2.95	2.97	3.36	2.07	2.13
Net Debt to NOPAT	-1.56	0.42	1.19	6.88	4.72	-5.18	1.66	2.55	2.99	-0.59	0.18
Long-Term Debt to NOPAT	0.09	1.20	1.62	6.41	4.40	-4.64	2.79	2.84	3.29	1.95	1.99
Altman Z-Score	4.58	4.63	4.09	3.35	3.25	3.00	3.45	3.50	3.56	4.09	3.78
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.08	2.10	1.95	1.92	2.11	1.67	1.66	1.87	2.11	2.10	2.01
Quick Ratio	1.08	1.06	1.06	0.95	0.77	0.66	0.86	0.94	1.00	1.15	1.12
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-20	-32	-47	-185	138	162	97	-137	-61	386	30
Operating Cash Flow to CapEx	363.75%	432.17%	1,072.17%	354.47%	276.56%	2,850.05%	4,941.47%	-1,815.65%	-358.44%	4,344.21%	1,355.89%
Free Cash Flow to Firm to Interest Expense	-11.16	-14.97	-14.71	-20.33	10.50	13.29	14.07	-20.96	-3.09	29.61	3.71
Operating Cash Flow to Interest Expense	42.03	24.58	29.51	2.72	1.22	14.89	16.85	-19.06	-1.81	28.52	14.02
Operating Cash Flow Less CapEx to Interest Expense	30.47	18.89	26.76	1.95	0.78	14.37	16.51	-20.11	-2.31	27.86	12.99
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	2.29	2.39	2.22	1.73	1.62	1.62	1.87	1.96	1.89	1.69	1.71
Accounts Receivable Turnover	6.52	6.54	5.96	4.93	5.56	6.31	6.23	5.44	5.11	4.88	5.00
Inventory Turnover	5.47	5.73	5.84	4.96	4.97	5.34	6.05	5.72	4.87	4.50	5.28
Fixed Asset Turnover	82.11	71.55	65.50	48.84	0.00	0.00	0.00	0.00	0.00	0.00	94.04
Accounts Payable Turnover	6.27	6.55	6.47	5.20	5.44	5.71	5.14	4.60	4.75	4.47	4.44
Days Sales Outstanding (DSO)	55.96	55.78	61.21	74.01	65.68	57.88	58.63	67.13	71.44	74.73	73.04
Days Inventory Outstanding (DIO)	66.76	63.70	62.46	73.59	73.46	68.40	60.29	63.80	75.02	81.03	69.09
Days Payable Outstanding (DPO)	58.26	55.75	56.43	70.23	67.13	63.89	70.98	79.33	76.82	81.60	82.27
Cash Conversion Cycle (CCC)	64.47	63.74	67.25	77.37	72.01	62.38	47.93	51.60	69.64	74.16	59.86
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	706	802	909	1,133	1,069	861	812	1,040	1,199	883	918
Invested Capital Turnover	4.86	4.70	4.17	3.10	2.95	3.16	3.77	3.81	3.38	3.13	3.38
Increase / (Decrease) in Invested Capital	86	96	107	224	-65	-208	-49	228	159	-316	35
Enterprise Value (EV)	986	979	1,092	1,297	1,184	846	797	1,019	1,030	1,053	956
Market Capitalization	1,089	952	1,020	1,031	837	611	716	786	736	1,095	945
Book Value per Share	$28.27	$30.18	$33.07	$33.88	$35.56	$26.76	$28.71	$31.96	$36.36	$37.41	$40.11
Tangible Book Value per Share	$24.33	$24.57	$21.12	$16.87	$18.76	$13.51	$16.00	$20.12	$24.90	$27.53	$27.12
Total Capital	827	863	965	1,159	1,280	943	874	1,078	1,235	1,068	1,044
Total Debt	18	88	128	292	366	265	143	271	330	144	137
Total Long-Term Debt	5.97	77	97	249	323	211	135	260	323	136	128
Net Debt	-103	27	72	267	347	236	80	233	294	-41	11
Capital Expenditures (CapEx)	21	12	8.85	7.00	5.80	6.39	2.36	6.85	9.98	8.56	8.29
Debt-free, Cash-free Net Working Capital (DFCFNWC)	536	594	599	670	800	509	432	683	841	558	571
Debt-free Net Working Capital (DFNWC)	658	655	655	695	819	539	495	721	877	743	697
Net Working Capital (NWC)	645	644	625	652	776	484	487	710	870	735	687
Net Nonoperating Expense (NNE)	1.01	0.57	-9.04	5.65	16	147	38	2.55	8.43	-7.35	-6.97
Net Nonoperating Obligations (NNO)	-103	27	72	267	154	182	80	233	294	-41	11
Total Depreciation and Amortization (D&A)	12	17	25	35	34	36	34	30	29	28	31
Debt-free, Cash-free Net Working Capital to Revenue	16.65%	16.78%	16.80%	21.17%	24.60%	16.71%	13.71%	19.35%	22.20%	17.11%	18.76%
Debt-free Net Working Capital to Revenue	20.43%	18.51%	18.37%	21.97%	25.20%	17.67%	15.70%	20.43%	23.16%	22.80%	22.91%
Net Working Capital to Revenue	20.05%	18.19%	17.51%	20.60%	23.89%	15.90%	15.45%	20.10%	22.98%	22.56%	22.61%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.29	$2.40	$2.74	$1.30	$2.25	($7.59)	$0.42	$3.48	$3.57	$3.10	$3.05
Adjusted Weighted Average Basic Shares Outstanding	28.56M	26.47M	25.32M	25.52M	25.64M	25.38M	25.42M	25.50M	25.14M	24.87M	23.44M
Adjusted Diluted Earnings per Share	$2.27	$2.38	$2.71	$1.29	$2.24	($7.59)	$0.42	$3.45	$3.54	$3.06	$3.00
Adjusted Weighted Average Diluted Shares Outstanding	28.80M	26.69M	25.52M	25.62M	25.73M	25.38M	25.52M	25.76M	25.36M	25.22M	23.84M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	27.62M	25.63M	25.43M	25.59M	25.24M	25.36M	25.50M	25.19M	24.84M	24.03M	21.88M
Normalized Net Operating Profit after Tax (NOPAT)	68	65	64	60	92	44	56	91	98	73	70
Normalized NOPAT Margin	2.12%	1.84%	1.79%	1.88%	2.83%	1.45%	1.78%	2.59%	2.59%	2.24%	2.31%
Pre Tax Income Margin	3.10%	2.71%	2.84%	1.99%	2.57%	-2.36%	1.83%	3.36%	3.22%	3.06%	3.10%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	55.13	44.58	30.91	7.51	7.22	-5.35	8.86	18.52	6.78	7.94	11.38
NOPAT to Interest Expense	36.96	30.22	18.73	4.25	5.58	-3.72	7.00	14.00	4.97	5.35	8.06
EBIT Less CapEx to Interest Expense	43.57	38.89	28.16	6.74	6.78	-5.87	8.52	17.47	6.28	7.29	10.34
NOPAT Less CapEx to Interest Expense	25.41	24.54	15.97	3.49	5.14	-4.24	6.66	12.95	4.46	4.69	7.03
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	28.69%	157.51%	30.16%	0.00%	16.46%	-3.15%	0.00%	20.50%	17.43%	55.66%	148.88%

This table displays calculated financial ratios and metrics derived from ScanSource's official financial filings.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-1.57%	-7.15%	-12.50%	-15.01%	-21.23%	-11.49%	-15.52%	-6.34%	8.95%	-4.63%	2.54%
EBITDA Growth	-0.74%	-26.26%	4.88%	-41.25%	-17.21%	-2.41%	-44.05%	27.63%	18.86%	6.83%	-10.79%
EBIT Growth	0.74%	-31.44%	5.25%	-48.99%	-20.20%	-4.25%	-54.01%	34.22%	23.47%	14.80%	-5.18%
NOPAT Growth	-4.73%	-25.29%	-21.81%	-48.54%	-21.98%	-32.86%	-27.21%	28.45%	26.17%	46.35%	-4.91%
Net Income Growth	-5.69%	-35.81%	27.17%	-39.65%	-14.44%	9.99%	-47.89%	36.12%	24.81%	17.11%	-3.28%
EPS Growth	-2.56%	-35.11%	27.72%	-39.76%	-13.16%	13.11%	-45.74%	48.00%	31.82%	28.99%	7.14%
Operating Cash Flow Growth	80.60%	293.01%	335.15%	192.04%	458.69%	-52.07%	-109.79%	-58.75%	-86.03%	-48.22%	598.40%
Free Cash Flow Firm Growth	32.71%	105.86%	156.24%	227.53%	337.89%	1,720.44%	30.56%	-77.91%	-104.61%	-92.62%	-99.55%
Invested Capital Growth	15.32%	0.70%	-8.61%	-19.23%	-26.37%	-17.78%	-13.48%	-3.83%	3.95%	0.37%	1.55%
Revenue Q/Q Growth	6.96%	-7.48%	0.97%	-14.94%	-0.86%	3.95%	-3.62%	-5.71%	15.33%	-9.01%	3.63%
EBITDA Q/Q Growth	-16.55%	-10.41%	58.34%	-50.37%	17.59%	5.61%	-9.22%	13.20%	9.51%	-5.08%	-24.19%
EBIT Q/Q Growth	-20.58%	-13.10%	76.38%	-58.09%	24.25%	4.26%	-15.28%	22.30%	14.30%	-3.06%	-30.03%
NOPAT Q/Q Growth	-18.24%	-2.37%	12.94%	-42.92%	23.96%	-15.98%	22.45%	0.72%	21.76%	-2.54%	-20.44%
Net Income Q/Q Growth	-11.35%	-17.97%	112.07%	-60.87%	25.69%	5.45%	0.47%	2.22%	15.25%	-1.06%	-17.03%
EPS Q/Q Growth	-8.43%	-19.74%	111.48%	-61.24%	32.00%	4.55%	1.45%	5.71%	17.57%	2.30%	-15.73%
Operating Cash Flow Q/Q Growth	-127.83%	712.89%	-32.40%	153.31%	-65.82%	-18.10%	-113.80%	1,167.58%	-88.43%	203.61%	32.87%
Free Cash Flow Firm Q/Q Growth	24.08%	108.37%	958.05%	89.78%	41.62%	-35.98%	-24.12%	-67.89%	-129.57%	202.48%	-95.38%
Invested Capital Q/Q Growth	4.03%	-6.53%	-3.88%	-13.59%	-5.16%	4.37%	1.16%	-3.95%	2.51%	0.77%	2.35%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	11.47%	12.15%	11.39%	12.55%	13.04%	13.10%	13.61%	14.22%	12.93%	14.53%	13.43%
EBITDA Margin	3.62%	3.51%	5.50%	3.21%	3.80%	3.87%	3.64%	4.37%	4.15%	4.33%	3.17%
Operating Margin	2.88%	2.75%	3.03%	2.33%	2.93%	2.27%	2.47%	3.17%	3.30%	3.50%	2.33%
EBIT Margin	2.84%	2.67%	4.67%	2.30%	2.88%	2.89%	2.54%	3.29%	3.27%	3.48%	2.35%
Profit (Net Income) Margin	1.99%	1.76%	3.70%	1.70%	2.16%	2.19%	2.28%	2.47%	2.47%	2.69%	2.15%
Tax Burden Percent	80.18%	80.60%	81.72%	71.33%	70.92%	73.92%	86.52%	71.95%	73.06%	73.63%	84.92%
Interest Burden Percent	87.10%	81.80%	97.00%	103.76%	105.58%	102.45%	103.81%	104.33%	103.60%	104.92%	107.87%
Effective Tax Rate	27.14%	19.40%	18.28%	28.67%	29.08%	26.08%	13.48%	28.05%	26.94%	26.37%	15.08%
Return on Invested Capital (ROIC)	7.10%	7.38%	7.89%	5.52%	6.51%	5.20%	6.42%	7.43%	8.13%	8.39%	6.37%
ROIC Less NNEP Spread (ROIC-NNEP)	6.70%	5.76%	12.80%	5.75%	6.97%	9.03%	7.83%	-6.36%	4.68%	22.65%	10.31%
Return on Net Nonoperating Assets (RNNOA)	2.06%	1.62%	3.10%	0.82%	0.96%	1.01%	0.66%	0.07%	-0.08%	0.14%	0.38%
Return on Equity (ROE)	9.16%	9.00%	11.00%	6.35%	7.47%	6.21%	7.08%	7.50%	8.05%	8.53%	6.75%
Cash Return on Invested Capital (CROIC)	-5.46%	7.49%	16.66%	28.41%	37.07%	25.75%	20.12%	10.54%	3.30%	7.29%	5.91%
Operating Return on Assets (OROA)	5.38%	5.10%	8.57%	4.23%	4.88%	4.95%	4.41%	5.59%	5.57%	5.97%	4.12%
Return on Assets (ROA)	3.76%	3.36%	6.80%	3.13%	3.66%	3.75%	3.96%	4.19%	4.22%	4.61%	3.78%
Return on Common Equity (ROCE)	9.16%	9.00%	11.00%	6.35%	7.47%	6.21%	7.08%	7.50%	8.05%	8.53%	6.75%
Return on Equity Simple (ROE_SIMPLE)	0.00%	8.87%	9.25%	8.45%	0.00%	8.54%	6.99%	7.49%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	20	19	22	13	16	13	16	16	20	19	15
NOPAT Margin	2.10%	2.22%	2.48%	1.66%	2.08%	1.68%	2.13%	2.28%	2.41%	2.58%	1.98%
Net Nonoperating Expense Percent (NNEP)	0.41%	1.62%	-4.91%	-0.22%	-0.46%	-3.83%	-1.41%	13.79%	3.45%	-14.26%	-3.93%
Return On Investment Capital (ROIC_SIMPLE)	-	-	1.95%	-	-	-	1.53%	1.54%	1.87%	1.82%	1.47%
Cost of Revenue to Revenue	88.53%	87.85%	88.61%	87.45%	86.96%	86.90%	86.39%	85.78%	87.07%	85.47%	86.57%
SG&A Expenses to Revenue	7.85%	8.61%	7.56%	8.85%	9.18%	9.25%	9.89%	9.89%	8.81%	10.18%	10.19%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	8.59%	9.41%	8.35%	10.22%	10.11%	10.83%	11.14%	11.05%	9.63%	11.03%	11.09%
Earnings before Interest and Taxes (EBIT)	27	23	41	17	21	22	19	23	27	26	18
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	34	31	49	24	28	30	27	31	34	32	24
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.81	0.82	1.04	1.17	1.18	1.25	0.00	0.88	1.04	1.05	0.94
Price to Tangible Book Value (P/TBV)	1.19	1.18	1.41	1.60	1.61	1.89	0.00	1.32	1.54	1.54	1.44
Price to Revenue (P/Rev)	0.19	0.20	0.28	0.32	0.34	0.37	0.00	0.27	0.31	0.32	0.28
Price to Earnings (P/E)	8.20	9.27	11.21	13.90	14.21	14.68	0.00	11.81	13.20	12.93	11.60
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	12.20%	10.78%	8.92%	7.20%	7.04%	6.81%	0.00%	8.47%	7.57%	7.73%	8.62%
Enterprise Value to Invested Capital (EV/IC)	0.86	0.86	1.03	1.18	1.19	1.25	0.00	0.88	1.04	1.05	0.94
Enterprise Value to Revenue (EV/Rev)	0.27	0.26	0.31	0.32	0.32	0.37	0.00	0.27	0.31	0.32	0.30
Enterprise Value to EBITDA (EV/EBITDA)	6.30	6.29	7.19	7.95	7.99	8.80	0.00	6.80	7.85	7.86	7.39
Enterprise Value to EBIT (EV/EBIT)	7.67	7.76	8.86	10.06	10.18	11.27	0.00	9.19	10.49	10.30	9.55
Enterprise Value to NOPAT (EV/NOPAT)	10.48	10.48	12.88	14.75	15.11	18.16	0.00	13.07	14.80	13.77	12.76
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	9.02	5.67	3.63	2.83	3.58	0.00	4.96	8.51	10.73	6.99
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	11.45	5.92	3.70	2.73	4.39	0.00	8.23	32.18	14.46	16.09
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.36	0.27	0.18	0.15	0.16	0.16	0.16	0.16	0.15	0.15	0.13
Long-Term Debt to Equity	0.36	0.26	0.17	0.15	0.15	0.15	0.15	0.14	0.14	0.14	0.11
Financial Leverage	0.31	0.28	0.24	0.14	0.14	0.11	0.08	-0.01	-0.02	0.01	0.04
Leverage Ratio	2.34	2.24	2.15	2.06	2.10	2.01	1.88	1.90	1.95	1.91	1.90
Compound Leverage Factor	2.04	1.83	2.09	2.14	2.22	2.06	1.95	1.98	2.02	2.00	2.05
Debt to Total Capital	26.71%	21.33%	15.03%	13.38%	13.48%	13.65%	13.61%	13.42%	13.17%	12.93%	11.56%
Short-Term Debt to Total Capital	0.56%	0.71%	0.70%	0.72%	0.74%	1.09%	0.95%	0.92%	0.88%	0.92%	1.88%
Long-Term Debt to Total Capital	26.15%	20.62%	14.33%	12.66%	12.74%	12.56%	12.66%	12.50%	12.29%	12.01%	9.69%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	73.29%	78.67%	84.97%	86.62%	86.52%	86.35%	86.39%	86.58%	86.83%	87.07%	88.44%
Debt to EBITDA	2.02	1.63	1.09	1.06	1.09	1.11	1.29	1.20	1.13	1.10	0.99
Net Debt to EBITDA	1.80	1.35	0.80	-0.10	-0.31	0.00	0.29	-0.06	0.09	0.09	0.29
Long-Term Debt to EBITDA	1.98	1.57	1.04	1.00	1.03	1.02	1.20	1.12	1.05	1.02	0.83
Debt to NOPAT	3.36	2.71	1.95	1.96	2.07	2.29	2.49	2.31	2.13	1.92	1.70
Net Debt to NOPAT	2.99	2.25	1.43	-0.18	-0.59	0.01	0.55	-0.11	0.18	0.15	0.51
Long-Term Debt to NOPAT	3.29	2.62	1.86	1.86	1.95	2.11	2.32	2.15	1.99	1.78	1.43
Altman Z-Score	3.39	3.67	4.12	4.07	3.93	3.88	0.00	3.65	3.66	3.84	3.66
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.11	2.15	2.30	2.20	2.10	2.03	2.11	2.07	2.01	2.16	1.96
Quick Ratio	1.00	1.05	1.16	1.16	1.15	1.07	1.08	1.12	1.12	1.13	1.04
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-139	12	123	234	332	212	161	52	-15	16	0.72
Operating Cash Flow to CapEx	-444.93%	4,040.30%	2,479.37%	6,617.81%	4,310.16%	1,887.58%	-313.63%	4,648.98%	303.73%	969.14%	1,561.57%
Free Cash Flow to Firm to Interest Expense	-25.06	2.09	36.74	117.04	159.00	100.68	81.79	28.18	-7.29	8.19	0.37
Operating Cash Flow to Interest Expense	-2.74	16.75	18.82	80.04	26.24	21.26	-3.14	35.98	3.64	12.13	15.85
Operating Cash Flow Less CapEx to Interest Expense	-3.36	16.33	18.06	78.83	25.63	20.13	-4.14	35.21	2.44	10.88	14.83
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.89	1.91	1.84	1.84	1.69	1.71	1.74	1.70	1.71	1.72	1.76
Accounts Receivable Turnover	5.11	5.18	4.98	5.43	4.88	5.02	4.99	5.16	5.00	5.35	5.24
Inventory Turnover	4.87	4.92	4.74	4.76	4.50	4.77	4.92	5.12	5.28	5.13	5.31
Fixed Asset Turnover	0.00	0.00	0.00	96.03	0.00	0.00	0.00	90.68	94.04	92.23	97.06
Accounts Payable Turnover	4.75	4.93	4.91	5.03	4.47	4.62	4.95	4.69	4.44	4.67	4.75
Days Sales Outstanding (DSO)	71.44	70.48	73.25	67.20	74.73	72.72	73.19	70.73	73.04	68.28	69.68
Days Inventory Outstanding (DIO)	75.02	74.16	77.07	76.69	81.03	76.58	74.14	71.30	69.09	71.12	68.73
Days Payable Outstanding (DPO)	76.82	73.97	74.32	72.54	81.60	78.96	73.72	77.77	82.27	78.08	76.76
Cash Conversion Cycle (CCC)	69.64	70.67	76.00	71.36	74.16	70.34	73.61	64.27	59.86	61.32	61.64
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,199	1,121	1,077	931	883	921	932	895	918	925	947
Invested Capital Turnover	3.38	3.33	3.19	3.32	3.13	3.09	3.01	3.26	3.38	3.26	3.22
Increase / (Decrease) in Invested Capital	159	7.75	-101	-222	-316	-199	-145	-36	35	3.40	14
Enterprise Value (EV)	1,030	958	1,113	1,095	1,053	1,155	0.00	791	956	973	893
Market Capitalization	736	753	989	1,109	1,095	1,154	0.00	798	945	963	857
Book Value per Share	$36.36	$36.84	$38.19	$37.51	$37.41	$38.32	$37.83	$38.43	$40.11	$41.77	$41.51
Tangible Book Value per Share	$24.90	$25.62	$28.04	$27.61	$27.53	$25.39	$25.21	$25.79	$27.12	$28.53	$27.08
Total Capital	1,235	1,163	1,122	1,090	1,068	1,066	1,043	1,042	1,044	1,050	1,030
Total Debt	330	248	169	146	144	146	142	140	137	136	119
Total Long-Term Debt	323	240	161	138	136	134	132	130	128	126	100
Net Debt	294	205	124	-13	-41	0.52	31	-6.53	11	11	36
Capital Expenditures (CapEx)	3.43	2.32	2.55	2.42	1.27	2.38	1.97	1.42	2.52	2.40	1.98
Debt-free, Cash-free Net Working Capital (DFCFNWC)	841	772	757	622	558	553	574	542	571	586	575
Debt-free Net Working Capital (DFNWC)	877	815	802	781	743	698	684	688	697	711	658
Net Working Capital (NWC)	870	806	795	773	735	686	674	678	687	701	639
Net Nonoperating Expense (NNE)	1.07	3.98	-11	-0.29	-0.58	-3.94	-1.10	-1.36	-0.52	-0.80	-1.32
Net Nonoperating Obligations (NNO)	294	205	124	-13	-41	0.52	31	-6.53	11	11	36
Total Depreciation and Amortization (D&A)	7.35	7.31	7.36	6.84	6.89	7.57	8.23	7.59	7.20	6.30	6.28
Debt-free, Cash-free Net Working Capital to Revenue	22.20%	20.75%	21.08%	17.97%	17.11%	17.50%	18.98%	18.22%	18.76%	19.50%	19.00%
Debt-free Net Working Capital to Revenue	23.16%	21.90%	22.33%	22.57%	22.80%	22.10%	22.64%	23.13%	22.91%	23.66%	21.77%
Net Working Capital to Revenue	22.98%	21.68%	22.11%	22.34%	22.56%	21.73%	22.31%	22.81%	22.61%	23.33%	21.13%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.76	$0.62	$1.31	$0.51	$0.66	$0.70	$0.72	$0.75	$0.88	$0.90	$0.75
Adjusted Weighted Average Basic Shares Outstanding	25.14M	24.89M	25.04M	25.03M	24.87M	24.15M	23.81M	23.28M	23.44M	22.02M	21.87M
Adjusted Diluted Earnings per Share	$0.76	$0.61	$1.29	$0.50	$0.66	$0.69	$0.70	$0.74	$0.87	$0.89	$0.75
Adjusted Weighted Average Diluted Shares Outstanding	25.36M	25.18M	25.33M	25.44M	25.22M	24.65M	24.22M	23.60M	23.84M	22.41M	22.11M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	24.84M	24.97M	25.17M	24.71M	24.03M	0.00	23.46M	22.60M	21.88M	21.94M	21.48M
Normalized Net Operating Profit after Tax (NOPAT)	20	19	22	15	16	17	17	17	20	19	16
Normalized NOPAT Margin	2.10%	2.22%	2.48%	2.03%	2.08%	2.16%	2.30%	2.37%	2.41%	2.61%	2.11%
Pre Tax Income Margin	2.48%	2.19%	4.53%	2.39%	3.04%	2.96%	2.64%	3.44%	3.38%	3.65%	2.53%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.84	4.19	12.29	8.65	10.31	10.63	9.64	12.65	12.65	13.44	9.25
NOPAT to Interest Expense	3.57	3.48	6.53	6.25	7.44	6.18	8.10	8.75	9.33	9.97	7.80
EBIT Less CapEx to Interest Expense	4.23	3.78	11.53	7.44	9.70	9.50	8.64	11.87	11.45	12.19	8.24
NOPAT Less CapEx to Interest Expense	2.96	3.06	5.77	5.04	6.83	5.05	7.10	7.98	8.13	8.71	6.78
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	17.43%	0.00%	19.17%	32.72%	55.66%	90.36%	149.35%	152.45%	148.88%	133.89%	125.68%

Financials Breakdown Chart

Key Financial Trends

Here’s a concise, investor‑oriented read on ScanSource (SCSC) using the latest quarterly data and the last four years of quarterly results. The focus is on cash flow trends, profitability, and balance‑sheet strength to help gauge liquidity and potential capital allocation moves.

Positive operating cash flow in Q2 2026: Net cash from continuing operating activities was $30,841,000, turning solidly positive after a negative print in Q2 2025.
Revenue held up at a high level in Q2 2026: Operating revenue was $766,512,000, up modestly year over year from Q2 2025’s $747,497,000, indicating resilient top line amid recent fluctuations.
Net income remained profitable in Q2 2026: Net income from continuing operations was $16,493,000, contributing to positive quarterly earnings per share.
Free cash flow appears positive for the quarter: Cash from operations (~$30.8M) exceeded capex (~$2.0M), suggesting cash generation available for growth initiatives or debt management.
Balance sheet debt position improved versus the prior quarter: Long‑term debt declined to $99,797,000 in Q2 2026 from $126,047,000 in Q1 2026, signaling deleveraging alongside ongoing financing activity.
Strong accumulated profitability metric: Retained earnings stood at about $1.027B, reflecting a long track record of profitable operations retained within equity.
Gross margin remains modest but stable: Gross margin sits in the mid‑teens (roughly 13.4% in Q2 2026), indicating a stable profitability base without sharp margin expansion in the period.
Working‑capital context remains elevated: Accounts receivable and inventories are elevated relative to cash, suggesting ongoing working‑capital deployment to support revenue levels.
Net cash from financing activities was negative in Q2 2026: Net financing cash flow was about $(50,318,000), driven by debt repayments and shareholder activity (e.g., share repurchases), reducing cash from financing channels this quarter.
Net cash from investing activities was negative in Q2 2026: Net cash used for investing was about $(20,333,000), reflecting acquisitions and capital expenditures that reduce near‑term cash despite supportive operating cash flow.

05/09/26 12:06 PM ETAI Generated. May Contain Errors.

ScanSource Financials - Frequently Asked Questions

According to the most recent income statement we have on file, ScanSource's financial year ends in June. Their financial year 2025 ended on June 30, 2025.

ScanSource's net income appears to be on an upward trend, with a most recent value of $71.55 million in 2025, rising from $65.42 million in 2015. The previous period was $77.06 million in 2024. Find out what analysts predict for ScanSource in the coming months.

ScanSource's total operating income in 2025 was $85.20 million, based on the following breakdown:

Total Gross Profit: $408.65 million
Total Operating Expenses: $323.45 million

Over the last 10 years, ScanSource's total revenue changed from $3.22 billion in 2015 to $3.04 billion in 2025, a change of -5.5%.

ScanSource's total liabilities were at $879.20 million at the end of 2025, a 2.9% increase from 2024, and a 31.6% increase since 2015.

In the past 10 years, ScanSource's cash and equivalents has ranged from $19.31 million in 2019 to $185.46 million in 2024, and is currently $126.16 million as of their latest financial filing in 2025.

Over the last 10 years, ScanSource's book value per share changed from 28.27 in 2015 to 40.11 in 2025, a change of 41.9%.

Related Companies

Financial statements for NASDAQ:SCSC last updated on 2/6/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ScanSource (SCSC) Financials

Financials Breakdown Chart

Key Financial Trends

ScanSource Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ScanSource (SCSC) Financials

Annual Income Statements for ScanSource

Quarterly Income Statements for ScanSource

Annual Cash Flow Statements for ScanSource

Quarterly Cash Flow Statements for ScanSource

Annual Balance Sheets for ScanSource

Quarterly Balance Sheets for ScanSource

Annual Metrics And Ratios for ScanSource

Quarterly Metrics And Ratios for ScanSource

Financials Breakdown Chart

Key Financial Trends

ScanSource Financials - Frequently Asked Questions

When does ScanSource's fiscal year end?

How has ScanSource's net income changed over the last 10 years?

What is ScanSource's operating income?

How has ScanSource's revenue changed over the last 10 years?

How much debt does ScanSource have?

How much cash does ScanSource have?

How has ScanSource's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools